Anjan Chatterjee told me that there just arent enough studies of these drugs in normal people. He said, In the situations where they do help, do they come with a cost? As he wrote in a recent letter to Nature , Most seasoned physicians have had the sobering experience of prescribing medications that, despite good intentions, caused bad outcomes. Given that cognitive enhancement is a choice, not a necessity, the cost-benefit calculation for neuroenhancers should probably be different than it is for, say, heart medications
We hope health care providers will catch up
BPC-157 Clinical Status Limited human data
Sticking to a lower dose for an extended period before increasing can help your body adjust
You would be like, Brother, you can't be like you're handing out a platter of food for these people